GI CANCERS

Latest News

Trial of PT886 and Pembrolizumab Doses First Patient With Gastric/GEJ Cancer
Trial of PT886 and Pembrolizumab Doses First Patient With Gastric/GEJ Cancer

October 10th 2024

The first patient with advanced gastric and gastroesophageal cancer has been dosed in a trial combining PT886 with pembrolizumab.

Namodenoson Earns FDA Orphan Drug Designation in Pancreatic Cancer
Namodenoson Earns FDA Orphan Drug Designation in Pancreatic Cancer

October 9th 2024

FDA Approves Cologuard Plus Stool DNA Test for Colorectal Cancer Screening
FDA Approves Cologuard Plus Stool DNA Test for Colorectal Cancer Screening

October 4th 2024

Assessing Targeted PET Imaging for Advanced Rectal Cancer
Assessing Targeted PET Imaging for Advanced Rectal Cancer

October 3rd 2024

FDA ODAC Votes Against Checkpoint Inhibitors in PD–L1-Negative Esophageal Cancer
FDA ODAC Votes Against Checkpoint Inhibitors in PD–L1-Negative Esophageal Cancer

September 26th 2024

Video Series
Video Interviews
Podcasts

More News